Suchergebnisse - "Ashworth, Simon"

PubPharm (7)

1

Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2009

von Vahdat, L. | Pruitt, B. | Fabian, C. | +16

2

Phase I study of eribulin mesylate administered once every 21 days in patients with advanced solid tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2009

von Tan, A. | Rubin, E. | Walton, D. | +5

CommentIn: Clin Cancer Res. 2009 Jun 15;15(12):3903-5. - PMID 19509144

3

Long-term survival of chronic dialysis patients following survival from an episode of multiple-organ failure

enthalten in: Critical care | 2009

von Chapman, R. | Templeton, M. | Ashworth, S. | +3

4

Long-term survival of chronic dialysis patients following survival from an episode of multiple-organ failure

enthalten in: Critical care | 2009

von Chapman, R. | Templeton, M. | Ashworth, S. | +3

5

Long-term survival of chronic dialysis patients following survival from an episode of multiple-organ failure

enthalten in: Critical care (London, England) | 2009

von Chapman, R. | Templeton, M. | Ashworth, S. | +3

6

Phase I Study of Eribulin Mesylate Administered Once Every 21 Days in Patients with Advanced Solid Tumors

enthalten in: Clinical cancer research | 2009

von Tan, A. | Rubin, E. | Walton, D. | +5

7

Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

enthalten in: Journal of clinical oncology / Englische Ausgabe | 2009

von Vahdat, L. | Pruitt, B. | Fabian, C. | +16

1
[1]